Pfizer and Biontech data show efficacy across age groups and races
COVID-19: Chinese Pharmaceuticals Do Not Announce Vaccine Phase 3 Clinical Trial Results: Pfizer Disclosures Details
November 13, 2020
Chinese pharmaceutical companies:
Chinese pharmaceutical companies do not disclose provisional data for Phase 3 vaccine clinical trials.
It is even more important for Chinese companies to publish all their data and be evaluated by their competitors.
National University of Singapore: Lee Kuan Yew Graduate School of Public Policy:
Associate Professor Younguk Ryu:
The problem is lack of transparency.
The right thing the Chinese government should do is
So that experts can scrutinize
Disclosure of test results and related information is of utmost importance.
City University of Hong Kong:
Associate Professor Nicholas Thomas (Public Health):
Chinese companies publish all data
To be evaluated by competitors
It shows the view that it is becoming more important.
“In order for the world to gain the trust of Chinese vaccines, the information sent must be transparent,” he said.
Bloomberg
https://www.bloomberg.co.jp/news/articles/2020-11-13/QJP85OT1UM0Z01
China Under Pressure to Reveal Vaccine Data After Pfizer Success
None of China ’s vaccine frontrunners have released key data
Difficult for China ’s adversaries to trust its vaccine trials
Western politicians
have faulted China for initial delays in providing information as the coronavirus spread around the world.Now as Beijing develops a vaccine, the need for transparency is proving essential to winback trust.
American drugmaker Pfizer Inc. and German biotechnology firm BioNTech SE
announced this week that its vaccine appears more than 90% effective in stopping Covid-19 infections.
The preliminary finding spurred a global stock rally and put the companies at the head of the pack in the race for the vaccine.
At around the same time, China
saw the final-stage trial of one of its top vaccine candidates halted in Brazil due to a serious adverse event.
While Brazil reversed its decision in less than 48 hours, the episode underscored the fraught geopolitical tensions around vaccine development:
Last month President Jair Bolsonaro
said China lacks credibility and people would n’t feel safe with the shot “due to its origin.”
Bloomberg